VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

Texas MPN Workshop 2022 | Tagraxofusp: a promising agent for the treatment of pediatric BPDCN

Naveen Pemmaraju, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, gives an overview of the challenges associated with treating pediatric blastic plasmacytoid dendritic cell neoplasm (BPDCN) and the promise of tagraxofusp for the treatment of these patients. This interview took place at the third annual Texas MPN Workshop (TMW) 2022, held in San Antonio, TX.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter